DOX Amdocs Limited

$56.97▼ -1.74% Unknown Other Last sync: just now Syncing
Key Metrics & Fundamentals
Market Cap
$6.05B
P/E Ratio
11.6
Div Yield
4.00%
52W Range
56.75 - 95.41
% vs 50 MA
-9.00%
% vs 200 MA
-22.41%
RSI-14
34.3
MACD Histogram
-0.3500
Beta (1Y vs SPY)
0.58
Free Cash Flow
$80.35M
Gross Rev
$1.17B
Gross Profit
$455.25M
EBITDA
$246.27M
COGS
$716.73M
Operating Exp
$261.99M
Operating Income
$193.26M
EBIT
$193.26M
Pretax Income
$176.89M
Net Income
$137.82M
EPS (Diluted)
1.28
Price & Volume History
Volume (M)
Financial Overview - Income Statement Quarterly
AI Analysis
Generated May 28, 8:12 PM
Company Overview

Amdocs Limited is a leading provider of software and services to communications and media companies globally, specializing in customer experience, billing, network automation, and digital transformation solutions. It holds a strong, established position within the telecom industry, serving many of the world's largest service providers with critical operational technologies.

Bull Case
  • The P/E ratio of 12.4 appears attractive, potentially offering a value entry point after a significant price correction from its 52-week high.
  • Amdocs provides essential software and services for telco operations, often leading to long-term contracts and a stable, recurring revenue base.
  • The ongoing global digital transformation within the telecom sector creates a sustained demand for Amdocs' expertise in modernizing networks and customer experiences.
  • The stock is down 34.9% from its 52-week high, suggesting it may be oversold and poised for a rebound if market sentiment or company-specific news improves.
Bear Case
  • The stock is in a strong downtrend, significantly below its 52-week high and trading well below both its 50-day and 200-day moving averages.
  • The current price of $62.08 is very close to its 52-week low of $59.40, indicating potential for further downside if key support levels are broken.
  • An RSI of 43.8 suggests a lack of strong buying interest and confirms the prevailing weak sentiment, without indicating an immediate oversold bounce.
  • The substantial price decline over the past year could signal deeper concerns among investors regarding future growth prospects, competitive pressures, or margin erosion.
Recent Performance

Amdocs has experienced a significant downturn, with its price falling 34.9% from its 52-week high and currently trading near its 52-week low. Despite a modest daily gain of 1.3%, the stock remains in a clear downtrend, trading below both its 50-day and 200-day moving averages. Technical indicators, including an RSI of 43.8, suggest continued weakness and a lack of strong buying momentum.

AI-generated analysis is for informational purposes only and does not constitute financial advice.

Not Financial Advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making any investment decisions. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙